NM_001004752.2:c.880C>G

Variant summary

Our verdict is Likely benign. The variant received -1 ACMG points: 0P and 1B. BP4

The NM_001004752.2(OR51F1):​c.880C>G​(p.Pro294Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000373 in 1,556,206 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

OR51F1
NM_001004752.2 missense

Scores

5
2
11

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.29

Publications

2 publications found
Variant links:
Genes affected
OR51F1 (HGNC:15196): (olfactory receptor family 51 subfamily F member 1) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. This olfactory receptor gene is a segregating pseudogene, where some individuals have an allele that encodes a functional olfactory receptor, while other individuals have an allele encoding a protein that is predicted to be non-functional. [provided by RefSeq, Jun 2015]
MMP26 (HGNC:14249): (matrix metallopeptidase 26) Proteins of the matrix metalloproteinase (MMP) family are involved in the breakdown of extracellular matrix in normal physiological processes, such as embryonic development, reproduction, and tissue remodeling, as well as in disease processes, such as arthritis and metastasis. The encoded preproprotein is proteolytically processed to generate the mature enzyme. This enzyme may degrade collagen type IV, fibronectin, fibrinogen, and beta-casein, and activate matrix metalloproteinase-9 by cleavage. The protein differs from most MMP family members in that it lacks a conserved C-terminal protein domain. The encoded protein may promote cell invasion in multiple human cancers. [provided by RefSeq, May 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -1 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.36501145).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OR51F1NM_001004752.2 linkc.880C>G p.Pro294Ala missense_variant Exon 1 of 1 ENST00000624103.2 NP_001004752.2 A6NLW9
MMP26NM_021801.5 linkc.-145+1718G>C intron_variant Intron 2 of 7 ENST00000380390.6 NP_068573.2 Q9NRE1
MMP26NM_001384608.1 linkc.-153+1718G>C intron_variant Intron 2 of 7 NP_001371537.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OR51F1ENST00000624103.2 linkc.880C>G p.Pro294Ala missense_variant Exon 1 of 1 6 NM_001004752.2 ENSP00000485387.2 A6NGY5A6NLW9
MMP26ENST00000380390.6 linkc.-145+1718G>C intron_variant Intron 2 of 7 5 NM_021801.5 ENSP00000369753.1 Q9NRE1
MMP26ENST00000300762.2 linkc.-153+1718G>C intron_variant Intron 2 of 7 1 ENSP00000300762.2 A0A8J8YUH5

Frequencies

GnomAD3 genomes
AF:
0.000210
AC:
32
AN:
152102
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000101
AC:
21
AN:
207836
AF XY:
0.000118
show subpopulations
Gnomad AFR exome
AF:
0.00102
Gnomad AMR exome
AF:
0.000138
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000206
GnomAD4 exome
AF:
0.0000185
AC:
26
AN:
1404104
Hom.:
0
Cov.:
33
AF XY:
0.0000203
AC XY:
14
AN XY:
691342
show subpopulations
African (AFR)
AF:
0.000535
AC:
17
AN:
31792
American (AMR)
AF:
0.000104
AC:
4
AN:
38462
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21592
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
76352
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50990
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5450
European-Non Finnish (NFE)
AF:
9.24e-7
AC:
1
AN:
1082428
Other (OTH)
AF:
0.0000692
AC:
4
AN:
57838
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.544
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000210
AC:
32
AN:
152102
Hom.:
0
Cov.:
32
AF XY:
0.000269
AC XY:
20
AN XY:
74304
show subpopulations
African (AFR)
AF:
0.000652
AC:
27
AN:
41406
American (AMR)
AF:
0.000262
AC:
4
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000253
ESP6500AA
AF:
0.000909
AC:
4
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000662
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Nov 24, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.859C>G (p.P287A) alteration is located in exon 1 (coding exon 1) of the OR51F1 gene. This alteration results from a C to G substitution at nucleotide position 859, causing the proline (P) at amino acid position 287 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.082
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.15
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.011
.;T
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.86
D;D
M_CAP
Benign
0.0062
T
MetaRNN
Benign
0.37
T;T
MetaSVM
Benign
-0.82
T
MutationAssessor
Pathogenic
3.7
.;H
PhyloP100
1.3
PrimateAI
Benign
0.21
T
PROVEAN
Pathogenic
-7.7
.;D
REVEL
Benign
0.26
Sift
Pathogenic
0.0
.;D
Polyphen
1.0
.;D
Vest4
0.21
MVP
0.59
ClinPred
0.95
D
GERP RS
5.4
Varity_R
0.54
gMVP
0.23
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139690464; hg19: chr11-4790289; API